Opioid Dependence : News

Healthline's Premium Tools

Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
... Award from the Association for Medical Education and Research in Substance Abuse (AMERSA). LaBelle, who manages BMC's Opioid Treatment Program and is also the program director of the State Technical Assistance Treatment Expansion of Office Based ...
Source:MediLexicon
Date:November 18, 2008
Taking strong opioid painkillers, in large doses,for an extended period of time, can causephysical dependence in humans.
Source:ClipSyndicate
Date:November 10, 2008
... research published in the November 5 issue of JAMA reveals that long-term therapy rather than short-term therapy for opioid-addicted adolescents yields better results. Those who received continuing treatment with the combination medication ...
Source:MediLexicon
Date:November 5, 2008
In the first clinical trial of a medication that was used for an extended time to treat opioid addiction in young adults, participants who received counseling and Suboxone for 12 weeks had substantially better ...
Source:Medical News
Date:November 4, 2008
Context The usual treatment for opioid-addicted youth is detoxification and counseling.
Source:Archives General Psychiatry
Date:November 4, 2008
... are needed to improve the effectiveness and/or minimize the abuse potential of therapeutic agents for drug abuse/dependence. Examples of such agents are buprenorphine and delta-9-tetrahydrocannabinol ( I' 9-THC). Buprenorphine has been approved for ...
Source:Business Wire
Date:October 28, 2008
... Buprenorphine Depot is a next generation proprietary formulation of the most widely used drug for the treatment of opioid dependence. In addition, Biotie gains access to a world-class drug discovery platform focussed on central nervous system and ...
Source:BioSpace
Date:October 24, 2008
... indicated for the management of persistent moderate to severe chronic pain that requires continuous, around-the-clock opioid administration for an extended period of time and that cannot be managed by other means such as non-steroidal analgesics, ...
Source:Pharmaceutical Online
Date:October 20, 2008
Advertisement
Back to Top